Skip to main content

Griffiths Richard Ian's Form 4 filing

Silence Therapeutics plc (SLN) · filed Apr 15, 2025

Accession no.
0001104659-25-035039
Filed
Apr 15, 2025
Trade date
Apr 10-15, 2025
Filing delay
5 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 5 derivative transactions. It was filed 5 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Griffiths Richard IanCIK 000184637010% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

This filing has no transactions of this kind.

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 10, 2025Ordinary SharesPPurchaseAcquired+75,579–F1–9,886,492Direct
Apr 11, 2025Ordinary SharesPPurchaseAcquired+169,440–F1–9,942,972Direct
Apr 14, 2025Ordinary SharesPPurchaseAcquired+121,227–F1–9,983,381Direct
Apr 14, 2025Ordinary SharesPPurchaseAcquired+150,000–F1–10,033,381Direct
Apr 15, 2025Ordinary SharesPPurchaseAcquired+83,754–F1–10,061,299Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.

Referenced by the price of 5 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)